FCC Compliance and RF Exposure Information

Operational Conditions

This device complies with part of the FCC Rules. Operation is subject to the following two conditions:

Modifications

Changes or modifications not expressly approved by the party responsible for compliance could void the user's authority to operate the equipment.

FCC Part 15 Compliance

Note: This equipment has been tested and found to comply with the limits for a Class B digital device pursuant to part 15 of the FCC Rules. These limits are designed to provide reasonable protection against harmful interference in a residential installation.

This equipment generates, uses, and can radiate radio frequency energy and, if not installed and used in accordance with the instructions, may cause harmful interference to radio communications. However, there is no guarantee that interference will not occur in a particular installation.

If this equipment does cause harmful interference to radio or television reception, which can be determined by turning the equipment off and on, the user is encouraged to try to correct the interference by one or more of the following measures:

Manufacturer Compliance Note

Important Note: Changes or modifications not expressly approved by the manufacturer responsible for compliance could void the user's authority to operate the equipment.

RF Exposure Information

The device has been evaluated to meet general RF exposure requirement. The device can be used in portable exposure condition without restriction.

Models: 1018U, 2ATOV-1018U, 2ATOV1018U, GoChek2 Connect Blood Glucose Meter, GoChek2 Connect, Blood Glucose Meter, Glucose Meter, Meter

PDF preview unavailable. Download the PDF instead.

GetApplicationAttachment.html?id=7844901 Acrobat Distiller 11.0 (Windows)

Related Documents

Preview MicroTech Medical 2022 Interim Report
An interim report for MicroTech Medical (Hangzhou) Co., Ltd. detailing financial and business highlights, management discussion and analysis, corporate governance, and product pipeline updates for the period ending June 30, 2022.